50

DAFTAR PUSTAKA

1. Indonesian Rheumatology Association. Diagnosis dan Penatalaksanaan

Osteoartritis. Rekomendasi IRA untuk Diagnosis dan Penatalaksanaan
Osteoartritis. Jakarta; 2014. 13 p.

2. Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, et

al. Accumulation of metabolic risk factors such as overweight,
hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk
of occurrence and progression of knee osteoarthritis: A 3-year follow-up of
the ROAD study. Osteoarthr Cartil [Internet]. 2012;20(11):1217–26.
Available from: http://dx.doi.org/10.1016/j.joca.2012.06.006

3. Brandt KD, Dieppe P, Radin E. Etiopathogenesis of Osteoarthritis. Med

Clin North Am. 2009;93(1):1–24.

4. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and
injuries 1990-2010: A systematic analysis for the Global Burden of Disease
Study 2010. Lancet. 2012;380(9859):2163–96.

5. Lawrence, Reva C.Lawrence RC, Felson DT, Helmick CG, Arnold LM,
Choi H, Deyo RA et al. Estimates of the prevalence of arthritis and other
rheumatic conditions in the United States. Part 2. Arthritis Rheum.
2008;58(1):26–35.

6. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The

global burden of hip and knee osteoarthritis: Estimates from the Global
Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.

7. Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee

osteoarthritis in India and related factors. Indian J Orthop [Internet]. 2016
Sep;50(5):518–22. Available from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017174/

8. Zhang YM, Wang J, Liu XG. Association between hypertension and risk of
knee osteoarthritis. Med (United States). 2017;96(32):1–7.
 51

9. Bell K, Twiggs J, Olin BR. Hypertension: The Silent Killer: Updated JNC-
8 Guideline Recommendation. 2015;1–8. Available from:
http://c.ymcdn.com/sites/www.aparx.org/resource/resmgr/CEs/CE_Hyperte
nsion_The_Silent_K.pdf

10. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology.

2007;46(12):1763–8.

11. Ishaan Vohra, Ajai Singh, Sabir Ali, N S Verma AK and VK. Correlation
of Hypertension with the severity of Osteoarthritis of Knee. Int J Biomed
Res. 2015;6(11):869–73.

12. Veronese N, Stubbs B, Solmi M, Smith TO, Noale M, Schofield P, et al.

Knee Osteoarthritis and Risk of Hypertension: A Longitudinal Cohort
Study. Rejuvenation Res [Internet]. 2017; Available from:
http://online.liebertpub.com/doi/10.1089/rej.2017.1917

13. Wijayanti L. Hubungan Hipertensi Dengan Tingkat Keparahan

Osteoarthritis. Univ Muhammadiyah Yogyakarta. 2017;

14. Azmi. Hubungan Derajat Dan Lama Menderita Hipertensi Dengan

Keparahan Osteoarthritis Lutut Di Rsudza Banda Aceh. Univ Syiah Kuala.
2017;

15. Mahajan A, Verma S, Tandon V. Osteoarthritis. Japi. 2005;53(July):634–

41.

16. WHO. Osteoarthritis. World Health [Internet]. 2013;12(Osteoarthritis in

Priority Medicines for Europe and the World 2013 Update):6–8. Available
from:
http://www.who.int/medicines/areas/priority_medicines/Ch6_12Osteo.pdf?
ua=1

17. Allen KD, Golightly YM, Hill C, Hill C, Hill C, Hill C. Epidemiology of
osteoarthritis: state of the evidence. Dep Heal Hum Serv USA.
2015;27(3):276–83.

18. Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res
 52

Clin Rheumatol. 2014;28(1):5–15.

19. Arismunandar R. the Relations Between Obesity and Osteoarthritis Knee in

Elderly Patients. 2015;4:110–6.

20. Maharani EP. FAKTOR-FAKTOR RISIKO OSTEOARTRITIS LUTUT

(Studi Kasus di Rumah Sakit Dokter Kariadi Semarang) [Tesis]. Univ
Diponegoro [Internet]. 2007; Available from:
http://eprints.undip.ac.id/17308/1/Eka_Pratiwi_Maharani.pdf

21. Chaganti RK, Lane NE. Risk factors for incident osteoarthritis of the hip
and knee. Curr Rev Musculoskelet Med. 2011;4(3):99–104.

22. Dickson DJ, Frcp M, Frcp G, Mrcgp L. Rheumatic Diseases 2005.

Education. 2005;4.

23. Zhang Y, Jordan JM. Epidemiology of Osteoarthritis. NIH Public Access.

2011;26(3):355–369.

24. Felson DT, Lawrence RC, Dieppe PA et al. Osteoarthritis: New Insights
Conference Part 1: The Disease and Its Risk Factors. Ann Intern Med
[Internet]. 2000;133(8):637–9. Available from:
http://www.annals.org/content/133/8/635.short

25. Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated

osteoarthritis. Curr Opin Rheumatol. 2017;29(2):214–22.

26. Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J,

Jordan KP. Current evidence on risk factors for knee osteoarthritis in older
adults: A systematic review and meta-analysis. Osteoarthr Cartil [Internet].
2015;23(4):507–15. Available from:
http://dx.doi.org/10.1016/j.joca.2014.11.019

27. Wittenauer R, Smith L, Aden K. Priority Medicines for Europe and the
World " A Public Health Approach to Innovation " Update on 2004
Background Paper Background Paper 6.12 Osteoarthritis. World Heal
Organ [Internet]. 2013;1–31. Available from:
http://www.who.int/medicines/areas/priority_medicines/BP6_12Osteo.pdf
 53

28. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex process

that involves the entire joint. J Med Life [Internet]. 2014;7(1):37–41.
Available from: /pmc/articles/PMC3956093/?report=abstract

29. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et

al. The American College of Rheumatology criteria for the classification
and reporting of osteoarthritis of the hip. Arthritis Rheum [Internet].
1991;34:505–14. Available from:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMe
d&dopt=Citation&list_uids=2025304

30. Oo WM, Bo MT. Role of Ultrasonography in Knee Osteoarthritis. JCR J

Clin Rheumatol [Internet]. 2016;22(6):324–9. Available from:
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&
an=00124743-201609000-00007

31. National Heart Foundation of Australia. Guideline for the diagnosis and
management of hypertension in adults. Guideline for the diagnosis and
management of hypertension in adults. 2016.

32. Paul K. Whelton et al. 2017 Guildline for Prevention, Detection, Evaluatio,
and Management of High Blood Pressure in Adults. J Am Coll Cardiol.
2017;70(14):1785–822.

33. Katherine T. Mills, Joshua D. Bundy, MPH, Tanika N. Kelly, Jennifer E.

Reed, Patricia M. Kearney, Kristi Reynolds, Jing Chen JH. Global
Disparities of Hypertension Prevalence and Control: A Systematic Analysis
of Population-based Studies from 90 Countries. HHS Public Access.
2016;134(6):441–50.

34. Bloch MJ. Worldwide prevalence of hypertension exceeds 1.3 billion. J

Am Soc Hypertens [Internet]. 2016;10(10):753–4. Available from:
http://dx.doi.org/10.1016/j.jash.2016.08.006

35. Kishore J, Gupta N, Kohli C, Kumar N. Prevalence of Hypertension and

Determination of Its Risk Factors in Rural Delhi. Int J Hypertens.
2016;2016.
 54

36. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar

(RISKESDAS) 2013. Lap Nas 2013. 2013;1–384.

37. Fotoula Babatsikou AZ. Epidemiology of hypertension in the elderly. Heal

Sci J. 2010;4(1).

38. Bolívar JJ. Essential hypertension: An approach to its etiology and

neurogenic pathophysiology. Int J Hypertens. 2013;2013.

39. Puar THK, Mok Y, Debajyoti R, Khoo J, How CH, Ng AKH. Secondary
hypertension in adults. Singapore Med J. 2016;57(5):228–32.

40. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C,

Handler J, et al. 2014 Evidence-Based Guideline for the Management of
High Blood Pressure in Adults. Jama [Internet]. 2014;311(5):507.
Available from:
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2013.284427

41. Report TS. The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Natl Institutes Heal Natl Hear Lung, Blood Inst [Internet].
2003;289(19):1206–52. Available from:
http://hyper.ahajournals.org/content/42/6/1206.short

42. Shin D. Association Between Metabolic Syndrome, Radiographic Knee

Osteoarthritis, and Intensity of Knee Pain: Results of a National Survey. J
Clin Endocrinol Metab [Internet]. 2014;99(9):3177–83. Available from:
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2014-1043

43. Conaghan PG, Vanharanta H, Dieppe PA. Is progressive osteoarthritis an

atheromatous vascular disease? Ann Rheum Dis. 2005;64(11):1539–41.

44. Nguyen T V. Osteoarthritis in southeast Asia. Int J Clin Rheumtol

[Internet]. 2014;9(5):405–8. Available from:
http://www.futuremedicine.com/doi/abs/10.2217/ijr.14.42

45. Cameron AC, Lang NN, Touyz RM. Drug Treatment of Hypertension:
Focus on Vascular Health. Drugs. 2016;76(16):1529–50.
 55

46. Schiffrin EL. Beyond blood pressure: the endothelium and atherosclerosis
progression. Am J Hypertens [Internet]. 2002;15(10 Pt 2):115S–122S.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12383592

47. Nurjanah A. Hubungan Antara Lama Hipertensi dengan Angka Kejadian

Gagal Ginjal Terminal di RSUD dr. Moewardi Surakarta. 2012;1–15.

48. Renna NF, De Las Heras N, Miatello RM. Pathophysiology of vascular

remodeling in hypertension. Int J Hypertens. 2013;2013.